Zynfuse
Zynfuse
In modern orthopedics, particularly sports medicine and soft tissue reconstruction, the transition from permanent metallic hardware to bioabsorbable suture anchors represents a major clinical milestone. Historically, permanent titanium or PEEK (polyetheretherketone) implants were the gold standard. However, their lifelong retention often caused issues, including artifact interference in postoperative MRI scans, permanent hardware migration, bone resorption secondary to stress shielding, and the risk of complicated secondary surgeries for implant retrieval.
Bioabsorbable suture anchors resolve these challenges. Engineered from specialized biocompatible and bioresorbable polymers, these devices provide strong mechanical fixation during the critical phase of soft tissue healing (first 6 to 12 weeks). They then undergo gradual hydrolytic degradation, eventually being completely replaced by host trabecular bone structure.
At Zynfuse Medical Technology Co., Ltd., we utilize advanced material science—blending Poly-L-Lactic Acid (PLLA), Poly-D,L-Lactic Acid (PDLLA), and Polyglycolic Acid (PGA) with osteoconductive ceramics like Beta-Tricalcium Phosphate (β-TCP) and Hydroxyapatite (HA)—to customize degradation profiles. This ensures that the structural integrity of the implant matches the biological healing timeline of ligamentous tissue.
Zynfuse Medical Technology Co., Ltd. is a professional orthopedic medical device manufacturer specializing in bone fusion and advanced implant systems for surgical innovation. Founded in 2016, we draw on 12 years of industry experience and 7 years of export experience to serve medical distributors, hospital procurement departments, and orthopedic surgical clinics worldwide.
Adjust thread pitch, eyelet dimensions, drive designs, and total implant lengths to accommodate specific surgical techniques and tissue densities.
Choose from high-strength PLLA, biocompatible PLLA-HA composites, or customized PLDLA/PGA matrices, tailored to target resorption curves and tensile strength requirements.
Integrate anchors with ultra-high molecular weight polyethylene (UHMWPE) non-absorbable sutures, customized needles, and ergonomic disposable insertion devices.
Our manufacturing facility features advanced machinery to handle strict polymer compounding, molding, ultra-precise Swiss-style lathe machining, and surface finishes. To prevent thermal degradation and chain scission in bioabsorbable polymers during processing, we maintain cleanroom environments with strictly controlled humidity and temperature.
To ensure bioabsorbable anchors perform safely in vivo, our quality management system relies on strict testing protocols. With a dedicated team of 68 quality inspection specialists, Zynfuse carries out dimensional verification, fatigue testing, biocompatibility evaluations, and mechanical shear testing on every batch.
Global orthopedic importers, hospital networks, and medical distributors face unique challenges when sourcing bioabsorbable implants. Key priorities include maintaining mechanical reliability, ensuring biopolymer purity, navigating strict regulatory approvals (such as CE MDR Class III and FDA 510(k)), and securing stable supply chains.
We provide a comprehensive framework to support your procurement needs:
We focus on Total Cost of Ownership (TCO) reduction without compromising clinical safety. By working directly with an OEM/ODM manufacturer like Zynfuse, you avoid distributor markups, gain access to specialized R&D expertise, and secure custom branding for your sports medicine catalog.
Traceable Materials
Regulatory Compliant
Incorporating bioactive glass fibers to promote rapid cellular responses, helping to accelerate bone remodeling and enhance soft-tissue integration.
Developing smart biopolymers that expand in response to body temperature, ensuring robust fit inside bone tunnels and minimizing the risk of pull-out failure.
Integrating drug-delivery functions to release localized anti-inflammatory agents or osteo-inductive proteins directly at the surgical site.
